StreetInsider.com News Articles

Form 8-K/A Wellgistics Health, Inc. For: May 27

Tue, 02 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260602/26591893.html

Form 8-K/A Wellgistics Health, Inc. For: May 27

Tue, 02 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260602/26591893.html

Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

Mon, 01 Jun 2026 07:40:00 -0400

Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progress
Recent capital raise provides capital into late 2026, including meeting criteria for DelivMeds AI transaction funding closing condition
Recent capital raise and debt restructuring preclude the Company from issuing shares for capital raising purposes until the earlier of seven (7) months from the transaction date and thirty (30) days after effectiveness of the resale registration statement covering the underlying securities.
Recent lock-up agreement to limit shares available for sale into the market
Exercise of warrants embedded

Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

Mon, 01 Jun 2026 07:40:00 -0400

Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progress
Recent capital raise provides capital into late 2026, including meeting criteria for DelivMeds AI transaction funding closing condition
Recent capital raise and debt restructuring preclude the Company from issuing shares for capital raising purposes until the earlier of seven (7) months from the transaction date and thirty (30) days after effectiveness of the resale registration statement covering the underlying securities.
Recent lock-up agreement to limit shares available for sale into the market
Exercise of warrants embedded

Form 8-K Wellgistics Health, Inc. For: May 27

Fri, 29 May 2026 17:30:00 -0400
si-local-file:///var/storage/secattach/20260529/26576739.html

Form 8-K Wellgistics Health, Inc. For: May 27

Fri, 29 May 2026 17:30:00 -0400
si-local-file:///var/storage/secattach/20260529/26576739.html

Wellgistics Health (WGRX) Announces Lock-Up Agreement with Holders of a Majority of its Common Stock

Thu, 28 May 2026 07:44:20 -0400

Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement
Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days.
"This lock-up agreement, when combined with the recent restructuring of our convertible liabilities and the raising of new funding, underscores the confidence our shareholders have in management to

Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock

Thu, 28 May 2026 07:40:00 -0400

Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement

TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days.
"This lock-up agreement, when combined with the recent restructuring

Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock

Thu, 28 May 2026 07:40:00 -0400

Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement

TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days.
"This lock-up agreement, when combined with the recent restructuring

Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M

Wed, 27 May 2026 17:50:00 -0400

New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes does not accrue interest and converts into common shares at $6.00 per share
Automatic Exchange provision automatically converts the New Debt into Preferred Stock upon the effectiveness of a registration statement and attainment of shareholder approval for the creation of Preferred Stock
The class of Preferred Stock that the New Convertible Debt exchanges into (the "Funding Preferred") converts into common shares at $50.00 per share
New funds raised satisfy

Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M

Wed, 27 May 2026 17:50:00 -0400

New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes does not accrue interest and converts into common shares at $6.00 per share
Automatic Exchange provision automatically converts the New Debt into Preferred Stock upon the effectiveness of a registration statement and attainment of shareholder approval for the creation of Preferred Stock
The class of Preferred Stock that the New Convertible Debt exchanges into (the "Funding Preferred") converts into common shares at $50.00 per share
New funds raised satisfy

Wellgistics Health completes 1-for-50 reverse stock split

Tue, 26 May 2026 08:05:58 -0400

Wellgistics Health Inc. (NASDAQ: WGRX) completed a 1-for-50 reverse stock split of its common shares, reducing outstanding shares from approximately 125.7 million to approximately 2.5 million shares.
The reverse split took effect at 12:01 a.m. Eastern Time on May 26, 2026, following stockholder approval on April 2, 2026. The company's common stock now trades under a new CUSIP number on the Nasdaq Capital Market.
Under the reverse split structure, every 50 previous shares automatically converted into one share of common stock. The company rounded up any fractional shares to the nearest whole share rather than issuing fractional shares.
The Tampa-based health technology company

Wellgistics Health completes 1-for-50 reverse stock split

Tue, 26 May 2026 08:05:58 -0400

Wellgistics Health Inc. (NASDAQ: WGRX) completed a 1-for-50 reverse stock split of its common shares, reducing outstanding shares from approximately 125.7 million to approximately 2.5 million shares.
The reverse split took effect at 12:01 a.m. Eastern Time on May 26, 2026, following stockholder approval on April 2, 2026. The company's common stock now trades under a new CUSIP number on the Nasdaq Capital Market.
Under the reverse split structure, every 50 previous shares automatically converted into one share of common stock. The company rounded up any fractional shares to the nearest whole share rather than issuing fractional shares.
The Tampa-based health technology company

Wellgistics Health Completes Reverse Split

Tue, 26 May 2026 08:00:00 -0400

1-for-50 reverse split of common shares outstanding now complete
2,513,425 common shares now outstanding
A new CUSIP was issued in connection with reverse split

TAMPA, FL / ACCESS Newswire / May 26, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it completed a 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock, par value $0.00001 per share (the "Common Stock"). The Reverse Split was approved by a majority of the stockholders

Wellgistics Health Completes Reverse Split

Tue, 26 May 2026 08:00:00 -0400

1-for-50 reverse split of common shares outstanding now complete
2,513,425 common shares now outstanding
A new CUSIP was issued in connection with reverse split

TAMPA, FL / ACCESS Newswire / May 26, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it completed a 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock, par value $0.00001 per share (the "Common Stock"). The Reverse Split was approved by a majority of the stockholders

Form 8-K Wellgistics Health, Inc. For: May 21

Thu, 21 May 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20260521/26535369.html

Form 8-K Wellgistics Health, Inc. For: May 21

Thu, 21 May 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20260521/26535369.html

CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders

Thu, 21 May 2026 10:50:00 -0400

This Press Release updates the information from the previous release.
Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare

TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today released a letter to shareholders expanding upon the strategy behind recently announced transactions.
'Dear Fellow Shareholders,
Yesterday we announced a series of transactions that, taken together, mark the most consequential strategic moment in Wellgistics

CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders

Thu, 21 May 2026 10:50:00 -0400

This Press Release updates the information from the previous release.
Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare

TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today released a letter to shareholders expanding upon the strategy behind recently announced transactions.
'Dear Fellow Shareholders,
Yesterday we announced a series of transactions that, taken together, mark the most consequential strategic moment in Wellgistics

Wellgistics Health Releases Letter to Our Shareholders

Thu, 21 May 2026 09:35:00 -0400

Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare

PHILADELPHIA, PA / ACCESS Newswire / May 21, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company"), a provider of data monetization, credentialing, digital engagement, and real-world asset ('RWA') tokenization technologies, today entered into a fully binding term sheet (the "Binding Term Sheet") with Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx^™ into its patented blockchain-enabled smart contracts platform PharmacyChain^™, today released a letter to shareholders expanding

Wellgistics Health Releases Letter to Our Shareholders

Thu, 21 May 2026 09:35:00 -0400

Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare

PHILADELPHIA, PA / ACCESS Newswire / May 21, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company"), a provider of data monetization, credentialing, digital engagement, and real-world asset ('RWA') tokenization technologies, today entered into a fully binding term sheet (the "Binding Term Sheet") with Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx^™ into its patented blockchain-enabled smart contracts platform PharmacyChain^™, today released a letter to shareholders expanding

Form 8-K Wellgistics Health, Inc. For: May 19

Thu, 21 May 2026 06:52:00 -0400
si-local-file:///var/storage/secattach/20260521/26531212.html

Form 8-K Wellgistics Health, Inc. For: May 19

Thu, 21 May 2026 06:52:00 -0400
si-local-file:///var/storage/secattach/20260521/26531212.html

Wellgistics Health executes 1-for-50 reverse stock split

Wed, 20 May 2026 18:00:18 -0400

Wellgistics Health Inc. (NASDAQ: WGRX) announced its board of directors approved a 1-for-50 reverse stock split of the company's common stock, effective at 12:01 a.m. Eastern Time on May 26, 2026.

The reverse split was approved by a majority of stockholders on April 2, 2026. The action is intended to increase the per-share trading price to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.

The reverse split will automatically convert every 50 current shares into one share of common stock. The company stated that no fractional shares will be issued, with any fractional shares

Wellgistics Health Announces Reverse Stock Split

Wed, 20 May 2026 18:00:00 -0400

TAMPA, FL / ACCESS Newswire / May 20, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx^™ into its patented blockchain-enabled smart contracts platform PharmacyChain^™, today announced that its board of directors approved the Company's 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock, par value $0.00001 per share (the "Common Stock"). The Reverse Split was approved by a majority of the stockholders of the Company on April 2, 2026. Post-split, the common